Stock listing
Turn Therapeutics Inc.
Selected listing: TTRX · NASDAQ · USD · US
Turn Therapeutics Inc. (NASDAQ:TTRX), Health Technology. Latest release Sep 10, 2026: Turn Therapeutics to Present at Stifel 2026 Virtual Immunology…
- Ticker
- NASDAQ:TTRX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Turn Therapeutics Inc.
The company focuses on developing innovative therapeutic solutions. Investors can find relevant information about Turn Therapeutics Inc. on its public company page.
Latest news from Turn Therapeutics Inc.
Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
September 10, 2026
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer
September 9, 2026
Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch
August 20, 2026
Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results
August 12, 2026
Turn Therapeutics to Ring the Nasdaq Closing Bell on Monday, August 10, 2026
July 28, 2026
Research Turn Therapeutics Inc.
Turn Therapeutics Inc. company profile
View the public company page for Turn Therapeutics Inc. on 6ix.
Turn Therapeutics Inc. news
Read company news and market updates connected to Turn Therapeutics Inc..
Turn Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Turn Therapeutics Inc..